Liquiritigenin-Loaded Submicron Emulsion Protects Against Doxorubicin-Induced Cardiotoxicity via Antioxidant, Anti-Inflammatory, and Anti-Apoptotic Activity

BACKGROUND: The clinical use of doxorubicin (DOX) is severely limited due to its cardiotoxicity. Thus, there is a need for prophylactic and treatment strategies against DOX-induced cardiotoxicity. PURPOSE: The purpose of this study was to develop a liquiritigenin-loaded submicron emulsion (Lq-SE) wi...

Descripción completa

Detalles Bibliográficos
Autores principales: Shi, Changcan, Wu, Hongjuan, Xu, Ke, Cai, Ting, Qin, Kunming, Wu, Li, Cai, Baochang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2020
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7034974/
https://www.ncbi.nlm.nih.gov/pubmed/32110010
http://dx.doi.org/10.2147/IJN.S235832

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7034974/
https://www.ncbi.nlm.nih.gov/pubmed/32110010
http://dx.doi.org/10.2147/IJN.S235832

Ejemplares similares